Long-Term GeneXpert Positivity after Treatment for Pulmonary Tuberculosis

Long-Term GeneXpert Positivity after Treatment for Pulmonary Tuberculosis

Tuberculosis (TB) is a cause of ill health and death worldwide. Since 2010, the diagnostic process has strongly relied on GeneXpert assays on biological specimens. Xpert MTB/RIF is an automated nucleic acid amplification test (NAAT) for Mycobacterium tuberculosis and rifampicin resistance, endorsed...

Full description

Bibliographic Details
Main Authors:	Luisa Costantini, Marco Marando, Pietro Gianella
Format:	Article
Language:	English
Published:	SMC MEDIA SRL 2020-07-01
Series:	European Journal of Case Reports in Internal Medicine
Subjects:	tuberculosis tb genexpert retested patients false positives
Online Access:	https://www.ejcrim.com/index.php/EJCRIM/article/view/1737

Similar Items

GeneXpert MTB/RIF assay – A major milestone for diagnosing Mycobacterium tuberculosis and rifampicin-resistant cases in pulmonary and extrapulmonary specimens
by: Shatha Thanoon Ahmed
Published: (2019-01-01)

Evaluation of stool GeneXpert MTB/RIF for the diagnosis of pulmonary tuberculosis among presumptive patients in Tanzania
by: Esther Ngadaya, et al.
Published: (2020-12-01)

GeneXpert Technology for the diagnosis of HIV-associated tuberculosis: Is scale-up worth it?
by: Saeed Muhammad, et al.
Published: (2020-06-01)

Evaluation of the geneXpert MTB/RIF assay for early diagnosis of tuberculosis and detection of rifampicin resistance in pulmonary and extrapulmonary specimens
by: Ali Albay, et al.
Published: (2016-09-01)

Utility of GeneXpert MTB/RIF assay for the diagnosis of pulmonary and extra-pulmonary tuberculosis, A report from Egypt
by: Enas, M. Hefzy, et al.
Published: (2021-02-01)

The limitations of the Cepheid GeneXpert® Mtb/Rif assay for the diagnosis and management of polyresistant pulmonary tuberculosis
by: Dahlia Hopmeier, et al.
Published: (2020-10-01)

Evaluation of GeneXpert as a new diagnostic tool for detection of pulmonary tuberculosis
by: Mohamed A Tag Eldin, et al.
Published: (2019-01-01)

Assessment of GeneXpert GxAlert platform for multi-drug resistant tuberculosis diagnosis and patients’ linkage to care in Tanzania
by: Nicholaus Peter Mnyambwa, et al.
Published: (2018-02-01)

Utility of GeneXpert in Diagnosis of Multidrug-resistant Extrapulmonary Tuberculosis
by: Ankush Chaudhary Speciality Medical Officer, et al.
Published: (2017-12-01)

Additional benefits of GeneXpert MTB/RIF assay for the detection of pulmonary tuberculosis patients with prior exposure to fluoroquinolones
by: Tang P, et al.
Published: (2018-12-01)

Valuing the use of GeneXpert test as an unconventional approach to diagnose pulmonary tuberculosis
by: Amany Omar, et al.
Published: (2019-07-01)

Evaluation of GeneXpert MTB/RIF for the detection of Mycobacterium tuberculosis and resistance to rifampin in extra-pulmonary specimens
by: Chema Marouane, et al.
Published: (2015-01-01)

geneXpert, is the India late?
by: Kapil Gandha
Published: (2013-09-01)

The additional yield of GeneXpert MTB/RIF test in the diagnosis of pulmonary tuberculosis among household contacts of smear positive TB cases
by: Dereje Habte, et al.
Published: (2016-08-01)

Evaluation of GeneXpert MTB for detection of Mycobacterium tuberculosis in Fayoum Governorate
by: Shrief R AbdelFattah, et al.
Published: (2020-01-01)

Magnetic Resonance Imaging and GeneXpert: A Rapid and Accurate Diagnostic Tool for the Management of Tuberculosis of the Spine
by: Ayush Sharma, et al.
Published: (2016-10-01)

Comparison of GeneXpert and line probe assay for detection of Mycobacterium tuberculosis and rifampicin-mono resistance at the National Tuberculosis Reference Laboratory, Kenya
by: S. A. Aricha, et al.
Published: (2019-10-01)

Comparison of Diagnostic Accuracy of Tuberculosis Spondylitis between Genexpert and Histopathological Examination
by: David Rudianto Salim, et al.
Published: (2021-03-01)

Study of diagnostic role of GeneXpert test in patients with pulmonary tuberculosis at El-Mahalla Chest Hospital
by: Hisham E.S Abd El Aaty, et al.
Published: (2021-01-01)

Diagnostic utility of GeneXpert MTB/RIF assay versus conventional methods for diagnosis of pulmonary and extra-pulmonary tuberculosis
by: Asmaa Mohammed Elbrolosy, et al.
Published: (2021-05-01)

Diagnosis of lymph node tuberculosis using the GeneXpert MTB/RIF in Tunisia
by: Taha Jaouadi, et al.
Published: (2015-01-01)

Comparison of GeneXpert MTB to Mycobacterium tuberculosis culture in children with tuberculosis
by: Betty Agustina, et al.
Published: (2019-05-01)

High prevalence of multidrug-resistant tuberculosis among patients with rifampicin resistance using GeneXpert Mycobacterium tuberculosis/rifampicin in Ghana
by: Justice K Boakye-Appiah, et al.
Published: (2016-01-01)

GeneXpert MTB/RIF and Mycobacterium tuberculosis Sputum Culture in Establishing the Diagnosis of Pulmonary Tuberculosis and Rifampicin Resistance in Suspected Childhood Pulmonary Tuberculosis in Soetomo Hospital
by: Berlian Beatrix Rarome, et al.
Published: (2020-12-01)

The role of genexpert in diagnosis of sputum-negative pulmonary tuberculosis
by: Mohamed Sedky, et al.
Published: (2018-01-01)

Evaluation of the Indian TrueNAT micro RT-PCR device with GeneXpert for case detection of pulmonary tuberculosis
by: Chaitali Nikam, et al.
Published: (2014-01-01)

Development of a Prototype GeneXpert Assay for Blood-Based Tuberculosis Case Finding
by: Siu, Kevin
Published: (2021)

Efficiency of Genexpert MTB/RIF in Patients with Newly Diagnosed and Recurrent Pulmonary Tuberculosis
by: Ye.N. Raznatovskaia, et al.
Published: (2015-04-01)

GeneXpert MTB-RIF assay as a rapid and effective molecular method for the diagnosis of tuberculosis in Erbil City
by: Salah Tofik Jalal
Published: (2019-12-01)

The Diagnostic Performance of Chest-X-Ray and Erythrocyte Sedimentation Rate in Comparison with GeneXpert® for Tuberculosis Case Notification Among Patients Living with Human Immunodeficiency Virus in a Resource-Limited Setting: A Cross-Sectional Study
by: Sorsa A
Published: (2020-09-01)

Incremental detection of pulmonary tuberculosis among presumptive patients by GeneXpert MTB/RIF® over fluorescent microscopy in Mwanza, Tanzania: an operational study
by: Jeremiah Seni, et al.
Published: (2015-06-01)

Evaluation of GeneXpert Mycobacterium tuberculosis/Rifampin for the detection of Mycobacterium tuberculosis complex and rifampicin resistance in nonrespiratory clinical specimens
by: Maya Habous, et al.
Published: (2019-01-01)

Surveillance for multi-drug and rifampicin resistant tuberculosis and treatment outcomes among previously treated persons with tuberculosis in the era of GeneXpert in rural eastern Uganda
by: Jonathan Izudi, et al.
Published: (2020-05-01)

Rifampicin resistance in mycobacterium tuberculosis patients using GeneXpert at Livingstone Central Hospital for the year 2015: a cross sectional explorative study
by: Sepiso K. Masenga, et al.
Published: (2017-09-01)

Validitas Metode Polymerase Chain Reaction GeneXpert MTB/RIF pada Bahan Pemeriksaan Sputum untuk Mendiagnosis Multidrug Resistant Tuberculosis
by: Nurlina Sirait, et al.
Published: (2013-12-01)

Utility of GeneXpert Mycobacterium tuberculosis/rifampicin assay in smear-negative pulmonary tuberculosis
by: Javeriya Mohammadi, et al.
Published: (2021-01-01)

Diagnostic accuracy of GeneXpert MTB/RIF in musculoskeletal tuberculosis: High sensitivity in tissue samples of HIV-infected and HIV-uninfected patients
by: M Held, et al.
Published: (2017-10-01)

Challenges with scale-up of GeneXpert MTB/RIF® in Uganda: a health systems perspective
by: Talemwa Nalugwa, et al.
Published: (2020-03-01)

Evaluation of the XpertMTB/RIF for the Diagnosis of Pulmonary Tuberculosis Among the Patients Attending DOTS Center Parsa District of Nepal
by: Roshan Kurmi, et al.
Published: (2016-12-01)

Comparative Yield of Tuberculosis during Active Case Finding Using GeneXpert or Smear Microscopy for Diagnostic Testing in Nepal: A Cross-Sectional Study
by: Suman Chandra Gurung, et al.
Published: (2021-04-01)